Compare ABG & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ABG | STVN |
|---|---|---|
| Founded | 1996 | 1949 |
| Country | United States | Italy |
| Employees | N/A | N/A |
| Industry | Retail-Auto Dealers and Gas Stations | Containers/Packaging |
| Sector | Consumer Discretionary | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 3.7B |
| IPO Year | 2001 | 2021 |
| Metric | ABG | STVN |
|---|---|---|
| Price | $202.33 | $17.55 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 6 | 3 |
| Target Price | ★ $244.33 | $25.67 |
| AVG Volume (30 Days) | 242.4K | ★ 563.4K |
| Earning Date | 04-28-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 0.39% |
| EPS Growth | ★ 16.88 | N/A |
| EPS | ★ 25.13 | N/A |
| Revenue | ★ $17,999,000,000.00 | N/A |
| Revenue This Year | $5.51 | $9.67 |
| Revenue Next Year | $2.53 | $9.99 |
| P/E Ratio | ★ $8.12 | $27.15 |
| Revenue Growth | ★ 4.71 | N/A |
| 52 Week Low | $184.61 | $12.89 |
| 52 Week High | $274.50 | $28.00 |
| Indicator | ABG | STVN |
|---|---|---|
| Relative Strength Index (RSI) | 49.40 | 74.51 |
| Support Level | $187.30 | $13.58 |
| Resistance Level | $255.30 | $26.94 |
| Average True Range (ATR) | 7.73 | 0.78 |
| MACD | -0.07 | 0.27 |
| Stochastic Oscillator | 52.18 | 91.61 |
Asbury Automotive Group is a regional collection of automobile dealerships that went public in March 2002. The company operates 171 new-vehicle stores and 39 collision centers. Over 70% of new-vehicle revenue is from luxury and import brands. Asbury also offers third-party financing and insurance products and its own F&I products via Total Care Auto. Asbury operates in 15 states (mostly in Rocky Mountain states, Texas, the Northeast, and Southeast). Asbury store brands include Herb Chambers in the Northeast, McDavid and Park Place in Texas, Koons in the Washington, D.C. area, and the Larry H. Miller brand in the Western US. Asbury generated about $18 billion of revenue in 2025 and is based in the Atlanta area. The firm targets at least $30 billion of revenue sometime around 2030.
Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, It derives its majority revenue from Europe, Middle East and Africa.